Stocks · Health care · Services-Medical Laboratories

VERACYTE, INC.

VCYT Clue Score73
United States Fiscal year ends December CIK 0001384101 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Jonathan Wygant
10 Nov 2025
VP, Chief Accounting Officer
Sell
5,102
$42.33
$215.98K
Jonathan Wygant
7 Nov 2025
VP, Chief Accounting Officer
Sell
5,818
$40.21
$233.93K

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 8
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,166,749
History held since 4 Nov 2013